Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?

被引：0
|
作者：
Lee, Yong-ho [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Div Endocrinol & Metab,Dept Internal Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2015年 / 39卷 / 03期
关键词：
SITAGLIPTIN; RISK; DESIGN; TRIAL;
D O I：
10.4093/dmj.2015.39.3.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 inhibitors and angioedema: a class effect?
    Saisho, Y.
    Itoh, H.
    DIABETIC MEDICINE, 2013, 30 (04) : e149 - e150
  • [2] Dipeptidyl peptidase-4 inhibitor approaches
    Bloomgarden, Zachary
    JOURNAL OF DIABETES, 2017, 9 (01) : 5 - 7
  • [3] Dipeptidyl Peptidase-4 Inhibitors and the Risk of Heart Failure: Regression to the Truth?
    Zannad, Faiez
    Rossignol, Patrick
    CIRCULATION, 2019, 139 (03) : 362 - 365
  • [4] Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure?
    Bhatt, Deepak L.
    Cavender, Matthew A.
    JACC-HEART FAILURE, 2014, 2 (06) : 583 - 585
  • [5] The effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on gentamicin nephrotoxicity in mice
    Al Suleimani, Yousuf M.
    Abdelrahman, Aly M.
    Karaca, Turan
    Manoj, Priyadarsini
    Ashique, Mohammed
    Nemmar, Abderrahim
    Ali, Badreldin H.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1102 - 1108
  • [6] Mechanism by which dipeptidyl peptidase-4 inhibitors increase the risk of heart failure and possible differences in heart failure risk
    Sano, Motoaki
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 28 - 32
  • [7] Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure
    Ou, Shuo-Ming
    Chen, Hung-Ta
    Kuo, Shu-Chen
    Chen, Tzeng-Ji
    Shih, Chia-Jen
    Chen, Yung-Tai
    HEART, 2017, 103 (06) : 414 - 420
  • [8] No increased risk of hospitalization for heart failure for patients treated with dipeptidyl peptidase-4 inhibitors in Taiwan
    Chang, Chia-Hsuin
    Chang, Yi-Cheng
    Lin, Jou-Wei
    Caffrey, James L.
    Wu, Li-Chiu
    Lai, Mei-Shu
    Chuang, Lee-Ming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 14 - 20
  • [9] Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor
    Maita, Hiroki
    Kobayashi, Tadashi
    Akimoto, Takashi
    Osawa, Hiroshi
    Kato, Hiroyuki
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2022, 23 (02): : 124 - 125
  • [10] Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor
    Takedomi, Hironobu
    Sakata, Yasuhisa
    Tomonaga, Michito
    Naruse, Naomi
    Yukimoto, Takahiro
    Akutagawa, Takashi
    Tsuruoka, Nanae
    Shimoda, Ryo
    Kido, Shinichi
    Esaki, Motohiro
    INTERNAL MEDICINE, 2022, 61 (18) : 2731 - 2734
12345